Corporate Acquisitions

Mergers and Acquisitions Biotech Companies Alliance Pharma Johnson & Johnson Novartis Sanofi Job Losses Oncology Companies Generic Drug Market Kenvue

4 ARTICLES

2mo ago

FDA Approves First Over-the-Counter Tylenol–Naproxen Combination Pill

The decision clears a single-dose, 12-hour non-opioid pain option and may block direct copycat products for up to three years under an exclusivity claim.

3 ARTICLES

3mo ago

Novartis Says Del‑brax Study Met Endpoints and Reinforced Phase 3 Dosing

5 ARTICLES

7mo ago

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

6 ARTICLES

10mo ago

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

3 ARTICLES

last yr.

Novartis Ianalumab Meets Efficacy and Safety Goals in Phase 3 Sjögren’s Trials